B-Lymphoblastic Leukemia/lymphoma (B-ALL)

B-Lymphoblastic Leukemia/lymphoma, also known as b lymphoblastic leukemia/lymphoma, is related to b-lymphoblastic leukemia/lymphoma with hypodiploidy and b-lymphoblastic leukemia/lymphoma with hyperdiploidy. An important gene associated with B-Lymphoblastic Leukemia/lymphoma is KMT2A (Lysine Methyltransferase 2A), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs Vindesine and Rituximab have been mentioned in the context of this disorder. Affiliated tissues include b lymphoblasts and bone marrow, and related phenotypes are Decreased viability and Increased shRNA abundance (Z-score > 2)